Nouvelle Orléans
- GemOx (Gemcitabine + Oxaliplatin) versus Gem (Gemcitabine) in non resectable pancreatic adenocarcinoma : final results of the GERCOR /GISCAD Intergroup Phase III
Christophe Louvet et coll. - PHASE II TRIAL OF HIGH DOSE ADJUVANT CHEMO-RADIOTHERAPY (55 GY IN 5 WKS + 5FU CONTINUOUSLY) AFTER RESECTION OF PANCREATIC ADENOCARCINOMA.
J. Balosso et coll. - Capecitabine chemoradiation in the preoperative treatment of patients with rectal adenocarcinomas: a phase II GERCOR trial
O. Dupuis et coll. - OPTIMOX1 Study: Folfox in old patients with metastatic colorectal cancer. A GERCOR study
A. Figer et coll. - OPTIMOX 1 study : FOLFOX 7/LV5FU2 compared to FOLFOX 4 in patients with advanced colorectal cancer.
A de Gramont et coll. - OPTIMOX1 study:5-fluorouracil, folinic acid and oxaliplatin (FOLFOX) in poor prognosis patients with metastatic colorectal cancer. A GERCOR study.
C Tournigand et coll.